117 results match your criteria: "Lübeck Institute of Experimental Dermatology (LIED)[Affiliation]"
Toxicology
December 2024
BASF SE, Experimentelle Toxikologie und Ökologie, Carl-Bosch-Straße, Ludwigshafen am Rhein 67056, Germany.
The 9th German Pharm-Tox Summit (GPTS) and the 90th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) took place in Munich from March 13-15, 2024. The event brought together over 700 participants from around the world to discuss cutting-edge developments in the fields of pharmacology and toxicology as well as scientific innovations and novel insights. A key focus of the conference was on the rapidly increasing role of computational toxicology, artificial intelligence (AI), and machine learning (ML) into the field, marking a shift away from traditional methods and allowing the reduction of animal testing as primary tool for toxicological risk assessment.
View Article and Find Full Text PDFExp Dermatol
September 2024
Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
Front Pharmacol
July 2024
Institute of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany.
Medicinal polypharmacology is one answer to the complex reality of multifactorial human diseases that are often unresponsive to single-targeted treatment. It is an admittance that intrinsic feedback mechanisms, crosstalk, and disease networks necessitate drugs with broad modes-of-action and multitarget affinities. Medicinal polypharmacology grew to be an independent research field within the last two decades and stretches from basic drug development to clinical research.
View Article and Find Full Text PDFExp Dermatol
July 2024
Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
J Eur Acad Dermatol Venereol
January 2025
Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
J Dermatol Sci
May 2024
Department of Dermatology, University of Lübeck, Lübeck, Germany. Electronic address:
Background: Bullous pemphigoid (BP), the most common subepidermal autoimmune blistering disease, is classically defined by the presence of IgG autoantibodies directed against the hemidesmosomal proteins BP180 (type XVII collagen) and BP230 and the predominance of skin lesions. Several studies have addressed the role of anti-BP180 IgE in patients and experimental models, while data on anti-BP230 IgE are scarce.
Objective: To assess anti-BP230 IgE level by ELISA in BP sera and to correlate it with disease severity and clinical characteristics.
Eur J Dermatol
December 2023
2nd University Dermatology Department, Aristotle University School of Medicine, Thessaloniki, Greece.
Limited studies have explored pemphigus variations among different ethnic groups residing in their respective geographical locations. This bicontinental study aimed to compare clinical and immunological parameters in Indian and European pemphigus patients in complete remission, off therapy, or on minimal therapy. 105 patients (India, n= 75; Bulgaria, n=15; Greece, n=15) with pemphigus vulgaris (PV) or pemphigus foliaceous (PF) in complete remission on minimal therapy (n=64) or complete remission off therapy (n=41) were recruited.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
June 2024
Department of Dermatology, Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
Pharm Res
March 2024
Medicinal Chemistry and Systems Polypharmacology, Medical Systems Biology Division, Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck and University Medical Center Schleswig-Holstein, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Drugs with multiple targets, often annotated as 'unselective', 'promiscuous', 'multitarget', or 'polypharmacological', are widely considered in both academic and industrial research as a high risk due to the likelihood of adverse effects. However, retrospective analyses have shown that particularly approved drugs bear rich polypharmacological profiles. This raises the question whether our perception of the specificity paradigm ('one drug-one target concept') is correct - and if specifically multitarget drugs should be developed instead of being rejected.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
July 2024
Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
Life (Basel)
December 2023
Laboratory of Human Molecular Genetics, Department of Genetics, Federal University of Paraná (UFPR), Curitiba 81531-980, Brazil.
Mol Pharm
February 2024
Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
P-glycoprotein (P-gp, encoded in humans by the gene and in rodents by the genes) is a membrane transporter that can restrict the intestinal absorption and tissue distribution of many drugs and may also contribute to renal and hepatobiliary drug excretion. The aim of this study was to compare the performance and sensitivity of currently available radiolabeled P-gp substrates for positron emission tomography (PET) with the single-photon emission computed tomography (SPECT) radiotracer [Tc]Tc-sestamibi for measuring the P-gp function in the kidneys and liver. Wild-type, heterozygous (), and homozygous () knockout mice were used as models of different P-gp abundance in excretory organs.
View Article and Find Full Text PDFNeural Regen Res
August 2024
Institute of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany.
Front Immunol
December 2023
Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Biology, Plön, Germany.
Bullous pemphigoid (BP) is an autoimmune blistering disease that primarily affects the elderly. An altered skin microbiota in BP was recently revealed. Accumulating evidence points toward a link between the gut microbiota and skin diseases; however, the gut microbiota composition of BP patients remains largely underexplored, with only one pilot study to date, with a very limited sample size and no functional profiling of gut microbiota.
View Article and Find Full Text PDFJ Cheminform
November 2023
Drug Development and Chemical Biology, Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck and University Medical Center Schleswig-Holstein, Ratzeburger Allee 160, 23538, Lübeck, Germany.
The discovery of both distinctive lead molecules and novel drug targets is a great challenge in drug discovery, which particularly accounts for orphan diseases. Huntington's disease (HD) is an orphan, neurodegenerative disease of which the pathology is well-described. However, its pathophysiological background and molecular mechanisms are poorly understood.
View Article and Find Full Text PDFDrug Dev Res
February 2024
Department of Medical Education, Augsburg University Medicine, Augsburg, Germany.
At the core of complex and multifactorial human diseases, such as cancer, metabolic syndrome, or neurodegeneration, are multiple players that cross-talk in robust biological networks which are intrinsically resilient to alterations. These multifactorial diseases are characterized by sophisticated feedback mechanisms which manifest cellular imbalance and resistance to drug therapy. By adhering to the specificity paradigm ("one target-one drug concept"), research focused for many years on drugs with very narrow mechanisms of action.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
November 2023
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Front Immunol
August 2023
Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
Laminin 332 is a heterotrimeric structural protein of the basal membrane zone (BMZ) of the skin and adjacent mucosal tissues. The importance of laminin 332 for the structural integrity of the BMZ is demonstrated by mutations in any of the three genes encoding for its three chains causing variants of junctional epidermolysis bullosa. Autoimmunity against laminin 332 is observed in mucous membrane pemphigoid (MMP) and in the rare patients with orf-induced pemphigoid.
View Article and Find Full Text PDFActa Derm Venereol
August 2023
Department of Dermatology, University of Lübeck, Lübeck, Germany; Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
Mucous membrane pemphigoid is an autoimmune blistering disorder characterized by predominant involvement of surface-close epithelia and linear depositions of immunoreactants at the dermal-epithelial junction on direct immunofluorescence microscopy. A major diagnostic difficulty is the frequent need for multiple biopsies to facilitate the diagnosis. Although oesophageal involvement is a rare, but life-threatening manifestation, the relevance of oesophageal direct immunofluorescence sampling is unclear.
View Article and Find Full Text PDFExp Dermatol
November 2023
Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
Human skin equivalents (HSEs) are three-dimensional skin organ culture models raised in vitro. This review gives an overview of common techniques for setting up HSEs. The HSE consists of an artificial dermis and epidermis.
View Article and Find Full Text PDFBiology (Basel)
June 2023
Department of Pathology, Section of Neuropathology/Translational Neurodegeneration Research and Neuropathology Lab, University of Oslo (UiO) and Oslo University Hospital (OUS), Sognsvannsveien 20, 0372 Oslo, Norway.
Alzheimer's disease (AD), the leading cause of dementia, is a growing health issue with very limited treatment options. To meet the need for novel therapeutics, existing drugs with additional preferred pharmacological profiles could be recruited. This strategy is known as 'drug repurposing'.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
October 2023
Department of Dermatology, UMCG Center of Expertise for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Front Immunol
June 2023
Institute for Systemic Inflammation Research (ISEF), University of Lübeck, Lübeck, Germany.
Introduction: The function of the second receptor for the complement cleavage product C5a, C5aR2, is poorly understood and often neglected in the immunological context. Using mice with a global deficiency of , we have previously reported an important role of this receptor in the pathogenesis of the neutrophil-driven autoimmune disease (EBA). Based on analyses, we hypothesized that the absence of C5aR2 specifically on neutrophils is the cause of the observed differences.
View Article and Find Full Text PDFFront Immunol
May 2023
Department of Dermatology and Allergology, Philipps-Universität Marburg, Marburg, Germany.
Autoimmune blistering diseases (AIBD) are paradigms of autoantibody-mediated organ-specific autoimmune disorders that involve skin and/or mucous membranes. Compared to other autoimmune diseases, the pathogenicity of autoantibodies in AIBD is relatively well described. Pemphigus is a potentially lethal autoantibody driven autoimmune disorder with a strong HLA class II association.
View Article and Find Full Text PDF